&nbsp;

DPM-HelpSection-11-node-id.gif

Jan 2018

Document

DPM-HelpSection-12-grouped-node.gif

Jan 2018

Document

DPM-HelpSection-13-jump.gif

Jan 2018

Document

DPM-HelpSection-14-connected.gif

Jan 2018

Regimen

GEMC

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Adjuvant

Drugs Used:

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

DANAFARBER(INT-PEG)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

dexamethasone

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

DDGP

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

New Drug Funding Program

Pegaspargase - Extranodal Natural Killer/T-cell Lymphoma

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2022

Regimen

GCVP+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Funding:

ODB - General Benefit

prednisone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

GCVP+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Palliative

Funding:

ODB - General Benefit

prednisone

Drugs Used:

riTUXimab (Unfunded),

riTUXimab (subcut) (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Guidelines and Advice

Gastroscopy Standards and Quality Indicators for Ontario

Status: Current

Dec 1969

Guidelines and Advice

Guidelines on Management of Nausea and Vomiting and on Loss of Appetite, Anorexia, and Cachexia in Cancer

Status: Current
ID: ES SMG-2

Dec 1969

Document